These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 30854973)
1. Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers. Yin L; Xue Y; Shang Q; Zhu H; Liu M; Liu Y; Hu Q Curr Top Med Chem; 2019; 19(12):1059-1069. PubMed ID: 30854973 [TBL] [Abstract][Full Text] [Related]
2. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway. Zhou H; Lu J; Yang CY; Sun Y; Wang S Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237 [TBL] [Abstract][Full Text] [Related]
3. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer. Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947 [TBL] [Abstract][Full Text] [Related]
4. Targeting Protein Neddylation for Cancer Therapy. Zhou L; Jia L Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235 [TBL] [Abstract][Full Text] [Related]
5. Neddylation: a novel modulator of the tumor microenvironment. Zhou L; Jiang Y; Luo Q; Li L; Jia L Mol Cancer; 2019 Apr; 18(1):77. PubMed ID: 30943988 [TBL] [Abstract][Full Text] [Related]
6. Overactivated neddylation pathway as a therapeutic target in lung cancer. Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting Neddylation with MLN4924 Suppresses Growth and Delays Multicellular Development in Huber RJ; Kim WD; Mathavarajah S Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807046 [TBL] [Abstract][Full Text] [Related]
8. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification. Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067 [TBL] [Abstract][Full Text] [Related]
9. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F. Zhou W; Xu J; Tan M; Li H; Li H; Wei W; Sun Y Mol Cell; 2018 Jun; 70(6):1008-1024.e6. PubMed ID: 29932898 [TBL] [Abstract][Full Text] [Related]
10. Neddylation-Independent Activities of MLN4924. Mao H; Sun Y Adv Exp Med Biol; 2020; 1217():363-372. PubMed ID: 31898238 [TBL] [Abstract][Full Text] [Related]
11. Targeting neddylation E2s: a novel therapeutic strategy in cancer. Zheng YC; Guo YJ; Wang B; Wang C; Mamun MAA; Gao Y; Liu HM J Hematol Oncol; 2021 Apr; 14(1):57. PubMed ID: 33827629 [TBL] [Abstract][Full Text] [Related]
12. Protein neddylation and its alterations in human cancers for targeted therapy. Zhou L; Zhang W; Sun Y; Jia L Cell Signal; 2018 Apr; 44():92-102. PubMed ID: 29331584 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of NAE-dependent protein hyper-NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease. Lee-Law PY; Olaizola P; Caballero-Camino FJ; Izquierdo-Sanchez L; Rodrigues PM; Perugorria MJ; Azkargorta M; Elortza F; Martinez-Chantar ML; Aspichueta P; Marzioni M; Bujanda L; Drenth JPH; Banales JM United European Gastroenterol J; 2021 Sep; 9(7):848-859. PubMed ID: 34310849 [TBL] [Abstract][Full Text] [Related]
14. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma. Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191 [TBL] [Abstract][Full Text] [Related]
15. Disruption of protein neddylation with MLN4924 attenuates paclitaxel-induced apoptosis and microtubule polymerization in ovarian cancer cells. Hong X; Li S; Li W; Xie M; Wei Z; Guo H; Wei W; Zhang S Biochem Biophys Res Commun; 2019 Jan; 508(3):986-990. PubMed ID: 30545630 [TBL] [Abstract][Full Text] [Related]
16. The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice. Yu H; Luo H; Chang L; Wang S; Geng X; Kang L; Zhong Y; Cao Y; Wang R; Yang X; Zhu Y; Shi MJ; Hu Y; Liu Z; Yin X; Ran Y; Yang H; Fan W; Zhao BQ Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35101976 [TBL] [Abstract][Full Text] [Related]
17. Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication. Jiang Y; Jia L Anticancer Agents Med Chem; 2015; 15(9):1127-33. PubMed ID: 25742093 [TBL] [Abstract][Full Text] [Related]
18. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway. Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638 [TBL] [Abstract][Full Text] [Related]
19. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy. Nawrocki ST; Griffin P; Kelly KR; Carew JS Expert Opin Investig Drugs; 2012 Oct; 21(10):1563-73. PubMed ID: 22799561 [TBL] [Abstract][Full Text] [Related]
20. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells. Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]